man |
TDLo |
intravenous |
64mg/kg/16H-I (64mg/kg) |
BEHAVIORAL: TOXIC PSYCHOSIS |
Lancet. Vol. 1, Pg. 965, 1984. |
mouse |
LD50 |
intramuscular |
> 2gm/kg (2000mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
BEHAVIORAL: ATAXIA |
Chemotherapy Vol. 27(Suppl, |
mouse |
LD50 |
intraperitoneal |
> 10gm/kg (10000mg/kg) |
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Chemotherapy Vol. 27(Suppl, |
mouse |
LD50 |
intravenous |
10400mg/kg (10400mg/kg) |
|
Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. Vol. 17, Pg. 233, 1979. |
mouse |
LD50 |
oral |
> 10gm/kg (10000mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
BEHAVIORAL: ATAXIA |
Chemotherapy Vol. 27(Suppl, |
mouse |
LD50 |
subcutaneous |
> 10gm/kg (10000mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
BEHAVIORAL: ATAXIA |
Chemotherapy Vol. 27(Suppl, |
rabbit |
LD50 |
intramuscular |
> 300mg/kg (300mg/kg) |
|
Chemotherapy Vol. 27(Suppl, |
rabbit |
LD50 |
intravenous |
> 1500mg/kg (1500mg/kg) |
BEHAVIORAL: FOOD INTAKE (ANIMAL)
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION |
Chemotherapy Vol. 27(Suppl, |
rat |
LD50 |
intramuscular |
> 2gm/kg (2000mg/kg) |
|
Chemotherapy Vol. 27(Suppl, |
rat |
LD50 |
intraperitoneal |
> 10gm/kg (10000mg/kg) |
|
Chemotherapy Vol. 27(Suppl, |
rat |
LD50 |
intravenous |
> 8gm/kg (8000mg/kg) |
|
Chemotherapy Vol. 27(Suppl, |
rat |
LD50 |
oral |
10gm/kg (10000mg/kg) |
|
Chemotherapy Vol. 27(Suppl, |
rat |
LD50 |
subcutaneous |
> 10gm/kg (10000mg/kg) |
|
Chemotherapy Vol. 27(Suppl, |